Phase 3 2 trials
Phase 3
NCT00463437 Apr 2007 → Jan 2008 diphtheria , hepatitis B virus infection , pneumococcal infection , poliomyelitis +1 GlaxoSmithKline
Completed
No outcome recorded
Phase 3
NCT00327184 Apr → Nov 2006 haemophilus infectious disease , meningococcal infection GlaxoSmithKline
Completed
No outcome recorded
Comparator or background therapy 6 trials
Phase 2
NCT00134719 Background Apr 2005 → Jul 2006 haemophilus infectious disease , meningococcal infection GlaxoSmithKline
Completed
No outcome recorded
Phase 2
NCT00129116 Background Mar → Dec 2003 haemophilus infectious disease , meningococcal infection GlaxoSmithKline
Completed
No outcome recorded
Phase 2
NCT00127855 Background Mar 2003 → Feb 2004 haemophilus infectious disease , meningococcal infection GlaxoSmithKline
Completed
No outcome recorded
Phase 3
NCT00586612 Background Dec 2007 → Dec 2008 haemophilus infectious disease , meningococcal infection GlaxoSmithKline
Completed
No outcome recorded
Phase 3
NCT00322335 Background May → Jul 2006 haemophilus infectious disease , meningococcal infection GlaxoSmithKline
Completed
No outcome recorded
Phase 4
NCT00611559 Comparator Feb → Jun 2008 diphtheria , hepatitis B virus infection , poliomyelitis , tetanus GlaxoSmithKline
Completed
No outcome recorded
Show 1 more trial